Continuous renal replacement therapy in COVID-19-associated AKI: adding heparin to citrate to extend filter life-a retrospective cohort study.

Eduardo de Oliveira ValleCarla Paulina Sandoval CabreraClaudia Coimbra César de AlbuquerqueGiovanio Vieira da SilvaMárcia Fernanda Arantes de OliveiraGabriel Teixeira Montezuma SalesIgor SmolentzovBernardo Vergara ReichertLucia AndradeVictor Faria SeabraPaulo Ricardo Gessolo LinsCamila Eleuterio Rodrigues

Published in: Critical care (London, England) (2021)

In COV + AKI patients, adding systemic heparin to standard regional citrate anticoagulation may prolong CRRT filter patency by reducing clotting risk with a low risk of complications.

Keyphrases

acute kidney injury
venous thromboembolism
sars cov
end stage renal disease
coronavirus disease
ejection fraction
newly diagnosed
chronic kidney disease
growth factor
peritoneal dialysis
respiratory syndrome coronavirus
atrial fibrillation